AmerisourceBergen Corporation is scheduled to release first-quarter fiscal 2023 results on Feb 1, before the opening bell.
In the last reported quarter, the company delivered an earnings surprise of 1.95%. Its earnings beat estimates in three of the trailing four quarters and missed once, the average surprise being 2.63%.
Q1 Estimates
The Zacks Consensus Estimate for first-quarter fiscal 2023 revenues is pegged at $62.27 billion, indicating an improvement of 4.4% from the prior-year quarter. The consensus mark for earnings stands at $2.62 per share, suggesting growth of 1.6% from the year-ago reported figure.
Factors to Note
Sustained growth in specialty product sales, coupled with overall market growth at the U.S. Healthcare Solutions segment, may have favored the fiscal first-quarter performance. The commercial COVID-19 treatments recorded lower sales in the past two quarters, a trend that is likely to have continued in the soon-to-be-reported quarter. With respect to the U.S. Healthcare Solutions segment, revenues are expected to grow 6-8% in fiscal 2023. Consequently, this may get reflected in the fiscal first-quarter results. Our model suggests first-quarter revenues for this segment to be $55.8 billion.
In fiscal 2023, operating income at this segment is anticipated to grow by 2-4%. This, in turn, is likely to get reflected in the fiscal first-quarter results. Our model predicts the segment’s adjusted operating income to be $629.4 million for the first quarter.
Apart from this, the International Healthcare Solutions segment’s World Courier unit is likely to have exhibited solid performance in the fiscal first quarter. In fact, World Courier’s impressive track record as an international leader in specialty logistics has enabled AmerisourceBergen to lend support to customers globally despite a challenging COVID-induced environment and additional operational challenges. Moreover, Alliance Healthcare’s products are likely to have driven the top line in the first quarter. Our model suggests first-quarter revenues for this segment to be $6.5 billion.
Per the fiscal 2023 guidance, operating income at the International Healthcare Solutions segment is estimated to decline by 3-7%. This, in turn, is likely to get reflected in the fiscal first-quarter results. Our model predicts the segment’s adjusted operating income to be $94.3 million for the first quarter.
5 Stocks Set to Double
Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>
AmerisourceBergen Corporation is scheduled to release first-quarter fiscal 2023 results on Feb 1, before the opening bell.
In the last reported quarter, the company delivered an earnings surprise of 1.95%. Its earnings beat estimates in three of the trailing four quarters and missed once, the average surprise being 2.63%.
Q1 Estimates
The Zacks Consensus Estimate for first-quarter fiscal 2023 revenues is pegged at $62.27 billion, indicating an improvement of 4.4% from the prior-year quarter. The consensus mark for earnings stands at $2.62 per share, suggesting growth of 1.6% from the year-ago reported figure.
Factors to Note
Sustained growth in specialty product sales, coupled with overall market growth at the U.S. Healthcare Solutions segment, may have favored the fiscal first-quarter performance. The commercial COVID-19 treatments recorded lower sales in the past two quarters, a trend that is likely to have continued in the soon-to-be-reported quarter. With respect to the U.S. Healthcare Solutions segment, revenues are expected to grow 6-8% in fiscal 2023. Consequently, this may get reflected in the fiscal first-quarter results. Our model suggests first-quarter revenues for this segment to be $55.8 billion.
In fiscal 2023, operating income at this segment is anticipated to grow by 2-4%. This, in turn, is likely to get reflected in the fiscal first-quarter results. Our model predicts the segment’s adjusted operating income to be $629.4 million for the first quarter.
Apart from this, the International Healthcare Solutions segment’s World Courier unit is likely to have exhibited solid performance in the fiscal first quarter. In fact, World Courier’s impressive track record as an international leader in specialty logistics has enabled AmerisourceBergen to lend support to customers globally despite a challenging COVID-induced environment and additional operational challenges. Moreover, Alliance Healthcare’s products are likely to have driven the top line in the first quarter. Our model suggests first-quarter revenues for this segment to be $6.5 billion.
Per the fiscal 2023 guidance, operating income at the International Healthcare Solutions segment is estimated to decline by 3-7%. This, in turn, is likely to get reflected in the fiscal first-quarter results. Our model predicts the segment’s adjusted operating income to be $94.3 million for the first quarter.
5 Stocks Set to Double
Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>
Get the latest research report on LH - FREE
Get the latest research report on CAH - FREE
Get the latest research report on MCK - FREE